09. maj 2018∣
Immuno-oncology is a rapidly evolving field and has recently experienced a flurry of partnership deals.
17. apr 2018∣
The core strengths we see in Scanfil are its elastic business model and extensive experience in the electronics manufacturing services sector.
11. apr 2018∣
We believe DOF is well-positioned to take advantage of the upturn in the subsea market.
06. apr 2018∣
Xbrane is a biotechnology company focused on developing biosimilars and complex long-acting injectable generics.
12. mar 2018∣
Video game developer and publisher Starbreeze stands poised to profit from the global gaming market.
05. mar 2018∣
Nordea Markets | 15. Nov 2017
Martin O'rourke | 09. jan 2019
Nordea Markets | 19. Dec 2018
Nordea On Your Mind
Martin O'rourke | 28. jan 2019
Valuta & penningmarknad
Kristoffer Svensson | 17. Nov 2018